Wealthfront Advisers LLC Has $15.96 Million Stock Holdings in CME Group Inc. $CME

Wealthfront Advisers LLC decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 2.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,084 shares of the financial services provider’s stock after selling 1,735 shares during the quarter. Wealthfront Advisers LLC’s holdings in CME Group were worth $15,964,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Amundi increased its holdings in CME Group by 24.0% in the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after buying an additional 385,225 shares during the period. Truist Financial Corp boosted its position in shares of CME Group by 8.9% during the 3rd quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after acquiring an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC boosted its position in shares of CME Group by 86.0% during the 3rd quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after acquiring an additional 13,512 shares in the last quarter. Elevate Capital Advisors LLC increased its stake in CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after acquiring an additional 3,919 shares during the period. Finally, Victory Financial Group LLC raised its position in CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after purchasing an additional 2,302 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CME shares. Piper Sandler lifted their price objective on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. JPMorgan Chase & Co. raised their target price on CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research report on Thursday, February 5th. Bank of America boosted their price target on CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Morgan Stanley upped their price target on CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Jefferies Financial Group cut their price objective on CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a report on Monday, January 12th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $297.59.

CME Group Trading Down 0.2%

CME stock opened at $306.76 on Wednesday. The business has a fifty day moving average price of $278.05 and a 200 day moving average price of $273.40. CME Group Inc. has a fifty-two week low of $239.70 and a fifty-two week high of $309.35. The stock has a market capitalization of $110.62 billion, a price-to-earnings ratio of 27.49, a P/E/G ratio of 3.34 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.52 EPS. Analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

Insiders Place Their Bets

In other CME Group news, Director Dennis Suskind sold 748 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director owned 2,699 shares of the company’s stock, valued at $809,700. This represents a 21.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.